Department of Convergence Korean Medical Science, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Phytomedicine. 2021 Jun;86:153557. doi: 10.1016/j.phymed.2021.153557. Epub 2021 Mar 27.
Pine nut oil (PNO), a standardized and well-defined extract of Pinus koraiensis (Korean pine), has beneficial effects on wound healing, inflammatory diseases, and cancer. However, the explanation for the mechanism by which PNO reduces body fat remains uncertain. We performed a protein-protein interaction network (PPIN) analysis to explore the genes associated with pinolenic acid using the MEDILINE database from PubChem and PubMed. It was concluded through the PPIN analysis that PNO was involved in a neutral lipid biosynthetic process.
This study evaluated the effects of PNO predicted by the network analysis of fat accumulation in chronic obesity mouse models established by feeding a high fat diet (HFD) to C57BL/6J mice and explored potential mechanisms.
HFD mice were fed only HFD or HFD with PNO at 822 and 1644 mg/kg. After an oral administration of 7 weeks, several body weight and body fat-related parameters were examined, including the following: adipose weight, adipocyte size, serum lipid profiles, adipocyte expression of PPAR-γ, sterol regulatory element binding protein (SREBP)-1c, lipoprotein lipase (LPL) and leptin.
We showed that oral administration of PNO to HFD mice reduces body fat weight, fat in tissue, white adipose tissue weight, and adipocyte size. The serum cholesterol was improved in the HFD mice treated with PNO. Additionally, PNO has significantly attenuated the HFD-induced changes in the adipose tissue expression of PPAR-γ, SREBP-1c, LPL, and leptin.
The findings from this study based on the PPIN analysis suggest that PNO has potential as drug to reduce body fat through fat regulatory mechanisms by PPAR-γ and SREBP-1c.
松仁油(PNO)是红松(Pinuskoraiensis)的标准化和明确提取物,对伤口愈合、炎症性疾病和癌症有有益的影响。然而,PNO 减少体脂的机制尚不清楚。我们使用来自 PubChem 和 PubMed 的 MEDILINE 数据库进行蛋白质-蛋白质相互作用网络(PPIN)分析,以研究与松烯酸相关的基因。通过 PPIN 分析得出的结论是,PNO 参与了中性脂质生物合成过程。
本研究通过网络分析预测 PNO 对高脂饮食(HFD)喂养 C57BL/6J 小鼠建立的慢性肥胖小鼠模型中脂肪积累的影响,并探讨潜在机制。
HFD 小鼠仅喂食 HFD 或 HFD 加 822 和 1644mg/kg 的 PNO。口服给药 7 周后,检查了几项体重和体脂相关参数,包括以下指标:脂肪重量、脂肪细胞大小、血清脂质谱、脂肪细胞中过氧化物酶体增殖物激活受体-γ(PPAR-γ)、固醇调节元件结合蛋白-1c(SREBP-1c)、脂蛋白脂肪酶(LPL)和瘦素的表达。
我们表明,PNO 口服给药可减少 HFD 小鼠的体脂重量、组织脂肪、白色脂肪组织重量和脂肪细胞大小。PNO 改善了 HFD 小鼠的血清胆固醇。此外,PNO 显著减弱了 HFD 诱导的脂肪组织中 PPAR-γ、SREBP-1c、LPL 和瘦素表达的变化。
基于 PPIN 分析的这项研究结果表明,PNO 具有通过 PPAR-γ 和 SREBP-1c 调节脂肪机制来减少体脂的潜力。